血红蛋白和胆固醇会影响儿科移植接受者明显的塔克罗利斯清除-一项回顾性队列研究
Carmen Inés Rodríguez Cuellar1, Mara Medeiros2,3, Maria Esther Díaz González de Ferris4
1Department of Pediatrics, Universidad del Rosario, Bogota, Colombia.
Pediatric transplantation
|March 13, 2025
概括
较低的血红蛋白和较高的胆固醇水平可能会影响儿童移植患者的塔克罗利清除. 监测这些生化标志物可以帮助优化药物剂量和治疗药物监测 (TDM).
科学领域:
- 药理学和移植医学 药理学和移植医学
- 儿科脏病学 儿科脏病学
- 临床生物化学 临床生物化学
背景情况:
- 塔克罗利斯是一种重要的免疫抑制剂,具有狭窄的治疗指数和患者反应的显著变化.
- 治疗药物监测 (TDM) 对塔克罗利木斯是必不可少的,但需要了解超越遗传学的因素.
- 血红蛋白和脂质对儿科移植受体中塔克罗利斯的药理动力学的影响仍未得到充分研究.
研究的目的:
- 为了研究血红蛋白,白蛋白,胆固醇和高密度胆固醇对儿科移植接受者的塔克罗利斯表面清除 (CL/F) 的影响.
- 为了确定优化塔克罗利斯剂量策略的潜在生化标志物.
主要方法:
- 在接受塔克罗利斯的儿科移植患者 (2004-2018) 进行了回顾性队列研究.
- 使用药代动力学 (PK) 概况和回归方程,估计了明显清除 (CL/F).
- 使用单变量和多变量混合效应回归分析来评估生化参数对CL/F的影响.
主要成果:
- 血红蛋白 (r = -0.3767,p < 0.0001) 和高密度胆固醇 (r = -0.3973,p < 0.0001) 与塔克罗利斯CL/F有显著的相关性.
- 总胆固醇也与CL/F相关 (r = -0.1821,p = 0.0004).
- 多变量分析证实血红蛋白和胆固醇是塔克罗利斯CL/F的显著预测因子.
结论:
- 血红蛋白和胆固醇水平对儿科脏移植患者的塔克罗利斯表面清除有适度的影响.
- 较低的血红蛋白似乎会增加塔克罗利斯CL/F,而较高的胆固醇会降低血红蛋白.
- 将这些生化参数整合到TDM中可以优化塔克罗利斯剂量并改善患者的治疗结果.
相关概念视频
Hepatic Drug Clearance: Effect of Protein Binding
131
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
131
Hepatic Drug Clearance: Role of Transporters
31
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
31
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
62
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
62
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
156
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
156
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
67
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
67
Drug Elimination: The Concept of Clearance
2.5K
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
2.5K


